AstraZeneca Covid-19 vaccine shows promise in elderly, trial results by Christmas

AstraZeneca and Oxford University's potential Covid-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas. The data suggest that those aged over 70, who are at higher risk of serious illness and death from Covid-19, could build robust immunity.